Evidence map›Paper›PMID 36964521›Full record

ArticleBMC palliative care2023

Implementation, barriers, and recommendations for further development of advance care planning for the last phase of life in nursing homes in Germany (Gut-Leben): protocol for a mixed-methods study.

Stephanie Stiel, Anna Levke Brütt, Jona T Stahmeyer, Anne W E Bockelmann, Tanja Schleef, Anna Völkel, Falk Hoffmann

Full text read
In one paragraph

Article in BMC palliative care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stephanie Stiel *Institute for General Practice and Palliative Care, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany. stiel.stephanie@mh-hannover.de.ORCID http://orcid.org/0000-0002-5963-2526
Anna Levke Brütt *Junior Research Group for Rehabilitation Sciences, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Jona T StahmeyerHealth Services Research Unit, AOK Niedersachsen, Hannover, Germany.
Anne W E BockelmannDivision of Outpatient Care and Pharmacoepidemiology, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Tanja SchleefInstitute for General Practice and Palliative Care, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.
Anna VölkelJunior Research Group for Rehabilitation Sciences, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Falk HoffmannDivision of Outpatient Care and Pharmacoepidemiology, Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.

Funding

Gemeinsame Bundesausschuss 01VSF21040
6 · The paper itself

Abstract

backgroundNursing home entry often marks the transition into the end-of-life. In 2018, Germany legally introduced reimbursement for advance care planning (ACP according to § 132 g SGB V) in nursing homes that applied for ACP approval to improve end-of-life care. The Gut-Leben project aims to evaluate the implementation and barriers of ACP in nursing homes in Germany, with a special focus on the federal state of Lower Saxony, and provide practical recommendations for further development of end-of-life care.

methodsThis mixed-methods study spreads across five work packages (WP) over a three-year period. WP 1 will explore the approval process, implementation, and barriers to ACP in nursing homes. Data will be collected through a national postal survey in a random sample of n = 600. WP 2 will explore whether documented ACP reports are applicable as a data source for research (expecting up to 500 available ACP reports). In WP 3a and 3b, data on the ACP process will be collected in n = 15 approved nursing homes in Lower Saxony over a 12-months period. For WP 3a and WP 3b, data on ACP conversations (n = 600) and on end-of-life care paths (n = 300) will be collected by facilitators and nurses of the respective nursing homes. In WP 4, residents' characteristics upon entry and changes in these characteristics over the length of stay are analyzed, utilizing claims data from the AOK Lower Saxony (expected sample of about 100,000 people entering nursing homes over a 10-years period). WP 5 connects, interprets, and reflects on the findings from WP 1-4 through focus groups and individual interviews with facilitators, nursing staff, residents, relatives, and care providers. Within a participatory approach, a practice advisory board will be set up existing of personal of nursing homes and will be closely involved in the whole research process. DISCUSSION: In summary, the Gut-Leben project provides insight into the implementation and barriers of ACP in nursing homes according to German legislation for the first time, including practitioners' and residents' perspectives. Insights will help the further development of ACP in Germany through practical recommendations based on quantitative and qualitative data.

Indexed as

Advance Care PlanningTerminal CareAcetazolamideGermanyHumansNursing HomesTetracyclinesAcetazolamideTetracyclinesWP 1Advance care planning, Nursing homeEnd of life care

Identifiers

PMID36964521
PMCPMC10036959

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.